期刊文献+

过氧化物酶体增殖物激活受体δ+294T/C基因多态性与冠心病的关系

Relationship of peroxisome proliferation-activated receptor-delta +294T/C gene polymorphism with coronary heart disease
下载PDF
导出
摘要 目的探讨过氧化物酶体增殖物激活受体δ(peroxisome proliferation-activated receptor-delta,PPARδ)+294T/C基因多态性与冠心病的关系。方法运用聚合酶链式反应及限制酶片段长度多态性技术分析无血缘关系汉族人群[包括82例正常对照者(NC),120例冠心病(CHD)患者]的PPARδ+294T/C基因多态性,分析基因型频率、等位基因频率,并对不同基因型患者冠心病的危险性进行评价。结果两组间基因型分布差异有统计学意义(P<0.05);CHD组TC+CC基因型频率及C等位基因频率均明显高于NC组(P<0.05);C等位基因携带(TC+CC)者冠心病危险性高于TT基因型(C等位基因携带者OR:3.16,95%CI:1.39~7.14)。结论PPARδ+294T/C基因多态性与冠心病之间有重要的相关性,C等位基因携带可能是冠心病的的危险因素。 Objective To investigate the relationship between peroxisome proliferation-activated receptor-delta (PPARS) +294T/C gene polymorphism and coronary heart disease(CHD). Methods 202 kinless subjects of the Chinese Han were investigated in this study, including 82 normal controls (NC), and 120 cases diagnosed as CHD. The PPARδ+294T/C gene polymorphism was determined by polymerase chain reac-tion and restriction fragment length polymorphisms. The frequencies of PPARδ+294T/C genotypes and the "C"allele frequency were analyzed, to evaluate the risk for the CHD among variant genotypes. Results The genotype distribution was significantly different between the CHD and the NC (P 〈0.05).The frequencies of TC+CC genotype were higher in the CHD group those in the NC, and the CHD risk in the "C" allele carries was significantly higher than that in the TT homozygote carries ("C"allele carries OR:3.16,95 % CI:1.39-7.14). Conclusion There was evident association between PPARδ+294T/C gene polymorphism and coronary heart disease, "C"allele carries may be an independent risk factor of the coronary heart disease.
出处 《安徽医学》 2010年第1期11-14,共4页 Anhui Medical Journal
关键词 冠心病 多态性 限制性片段长度 过氧化物酶体增殖物激活受体Δ Coronary heart disease Polymorphism restriction fragment length Peroxisome proliferation-activated receptor-delta
  • 相关文献

参考文献13

  • 1Fruchart JC , Duriez P , Staels B. Peroxisome proliferators-activated receptor-alpha activators regulate genes governing liporprotain metabolism, vascular inflammation and atherosclerosis. Curr Opin Lipidol, 1999,10(3 ): 245-257.
  • 2高润霖.急性心肌梗死诊断和治疗指南[J].中华心血管病杂志,2001,29(12):710-725. 被引量:4927
  • 3Gouni-Berthod I , Giannakdou E , Faust M ,et al.The peroxisome proliferator- activated receptor +294T/C polymorphism in relation to lipoprotein metabolism in patients with diabetes mel litus type2 and in non--diabetic controls.Atherosclerosis,2005,183 (2):336-341.
  • 4Skogsberg J , Kannisto K , Cassel TN, et al .Evidence that peroxisome proliferator-activated receptor delta influences cholesterol metabolism in men. Arterioscler Thromb Vasc Bio1,2003,23 (4):637-643.
  • 5Barish GD, Narkae VA , Evans RM. PPARδ:a dagger in the heart of the metabolic syndrome. J Clin Invest,2006, 116(3): 590-597.
  • 6Aberle J , Hopfer I, Beil FU, et al. Association of the T+294C polymorphism in PPAR delta with low HDL cholesterol and coronary heart disease risk in women. Int J Med Sei,2006,3(3): 108-111.
  • 7Chen S, Tsybouleva N, Ballantyne CM, et al. Effects of PPA- Ralpha, gamma and delta haplotypes on plasma levels of lipids and progression of coronary atherosclerosis and response to statin therapy in the lipoprotein coronary atherosclerosis study. Pharmacogenetics, 2004, 14 (1) 61-71.
  • 8Oliver WR,Shenk JL, Snaith MR,et al.A selective peroxisome proliferator-activated receptor δagonist promotes reverse cholesterol transport. Proc Natl Acad Sci USA,2001,98(9):5306-5311.
  • 9Skogsberg J, McMahon AD,Karpe F,et al.Peroxisome proliferator activated receptor delta genotype in relation to cardiovascular risk factors and risk of coronary heart disease in hypercholesterolaemic men. J Internal Med, 2003,254: 597-604.
  • 10Aberle J,Hopfer I,Beil FU,et al.Association of the T+294C polymorphism in PPAR - with low HDL cholesterol and coronary heart disease risk in women. Int J Med Sci,2006,3 (3): 108-111.

共引文献4926

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部